Sugi Predict

Sugi Predict / Compounds / SCHEMBL295865

SCHEMBL295865

SCHEMBL295865

O=C(N[C@H](CO)C(=O)O)OCc1ccccc1

nearest known ligand 0.57

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ PPARA Q07869 3/20 0.57
▸ PPARG P37231 1/20 0.57
▸ CTSK P43235 3/20 0.57
▸ TACR1 P25103 2/20 0.57
▸ CTRB1 P17538 2/20 0.56
▸ CTSL P07711 1/20 0.56
▸ CTSB P07858 1/20 0.56
▸ CTSS P25774 1/20 0.56
▸ IDO1 P14902 1/20 0.55
▸ TDO2 P48775 1/20 0.55
▸ CASP1 P29466 2/20 0.54
▸ ALDH1A1 P00352 1/20 0.54
▸ ALOX15 P16050 1/20 0.54
▸ ITGB3 P05106 4/20 0.54
▸ ITGA2B P08514 4/20 0.54
▸ KYNU Q16719 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL457686 1.00 PPARA (0.57) PPARAPPARGCTSKTACR1CTRB1
SCHEMBL201710 1.00 PPARA (0.57) PPARAPPARGCTSKTACR1CTRB1
SCHEMBL9572336 0.94 CTSK (0.55) PPARAPPARGCTSKTACR1CTSL
SCHEMBL9572337 0.94 CTSK (0.55) PPARAPPARGCTSKTACR1CTSL
Alanine SCHEMBL28766518 0.92 CTSK (0.56) PPARAPPARGCTSKCTSLCTSB
SCHEMBL1192366 0.92 PPARA (0.51) PPARAPPARGCTSKTACR1CTRB1
SCHEMBL2677964 0.90 CTSK (0.57) CTSKTACR1CTRB1CTSLCTSB
SCHEMBL17446717 0.90 CTSK (0.57) CTSKTACR1CTRB1CTSLCTSB
SCHEMBL7032185 0.90 CTSK (0.57) CTSKTACR1CTRB1CTSLCTSB
SCHEMBL13503284 0.89 ALDH1A1 (0.64) CTSKTACR1CTRB1CTSLCTSB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 315 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109456731-B SBS asphalt waterproof coiled material and preparation method thereof 山东坤岳防水材料股份有限公司 2021-03-16 — — CN claimed
US-20130041180-A1 PROCESS FOR PREPARING (R)-2-ACETAMIDO-N-BENZYL-3-METHOXY-PROPIONAMIDE MSN LABORATORIES PRIVATE LIMITED (IN) 2013-02-14 — — US claimed
EP-2534127-A1 PROCESS FOR PREPARING (R)-2-ACETAMIDO-N-BENZYL-3-METHOXY-PROPIONAMIDE MSN Laboratories Limited (IN) 2012-12-19 — — EP claimed
WO-2011099033-A1 PROCESS FOR PREPARING (R)-2-ACETAMIDO-N-BENZYL-3-METHOXY-PROPIONAMIDE MSN LABORATORIES LIMITED (IN) 2011-08-18 — — WO claimed
EP-4714953-A1 MELANOCORTIN 2-TYPE RECEPTOR ANTAGONIST Scohia Pharma, Inc. (JP) 2026-03-25 — — EP disclosed
US-20260077038-A1 LIPID NANOPARTICLES FOR DELIVERY OF NUCLEIC ACIDS AND METHODS OF USE THEREOF AKAGERA MEDICINES, INC. (US) 2026-03-19 — — US disclosed
US-20260069684-A1 LIPID NANOPARTICLES FOR DELIVERY OF NUCLEIC ACIDS AND METHODS OF USE THEREOF AKAGERA MEDICINES, INC. (US) 2026-03-12 — — US disclosed
EP-4687883-A2 MODULATORS OF TRPML, THEIR COMPOSITIONS AND METHODS OF USE Caraway Therapeutics, Inc. (US) 2026-02-11 — — EP disclosed
EP-4419525-B1 HETEROCYCLIC COMPOUNDS FOR USE IN THE TREATMENT OF CANCER ARTIOS PHARMA LTD (GB) 2025-07-23 — — EP disclosed
US-20250230165-A1 HETEROCYCLIC COMPOUNDS FOR USE IN THE TREATMENT OF CANCER ARTIOS PHARMA LIMITED (GB) 2025-07-17 — — US disclosed
CN-119119033-A Pyrazolopyridone compounds 百济神州有限公司 2024-12-13 — — CN disclosed
WO-2024237266-A1 MELANOCORTIN 2-TYPE RECEPTOR ANTAGONIST 株式会社スコヒアファーマ 2024-11-21 — — WO disclosed
EP-0034347-B1 DERIVATIVES OF ALDOHEXOSES, INTERMEDIATES, PROCESS FOR THEIR PRODUCTION, PREPARATIONS CONTAINING SUCH COMPOSITIONS AND THEIR USE CIBA-GEIGY AG (CH) 1986-04-09 — — EP disclosed
US-4517379-A ARTIFICIAL SWEETENER PFIZER INC. (US) 1985-05-14 — — US disclosed
EP-0069811-B1 BRANCHED AMIDES OF L-ASPARTYL-D-AMINO ACID DIPEPTIDES AND COMPOSITIONS THEREOF PFIZER INC. (US) 1984-10-24 — — EP disclosed
US-4454328-A SWEETENERS PFIZER INC. (US) 1984-06-12 — — US disclosed
US-4406889-A IMMUNOLOGY, PEPTIDES CIBA-GEIGY CORPORATION (US) 1983-09-27 — — US disclosed
US-4399163-A ARTIFICIAL SWEETENERS PFIZER INC. (US) 1983-08-16 — — US disclosed
EP-0069811-A1 Branched amides of L-aspartyl-D-amino acid dipeptides and compositions thereof PFIZER INC. (US) 1983-01-19 — — EP disclosed
EP-0034347-A2 Derivatives of aldohexoses, intermediates, process for their production, preparations containing such compositions and their use CIBA-GEIGY AG (CH) 1981-08-26 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260069684-A1 LIPID NANOPARTICLES FOR DELIVERY OF NUCLEIC ACIDS AND METHODS OF USE THEREOF PHOSPHO1, PLTP, SGMS1 PPARA 442/4885PPARG 334/4885CTSK 4184/4885
US-20260077038-A1 LIPID NANOPARTICLES FOR DELIVERY OF NUCLEIC ACIDS AND METHODS OF USE THEREOF PHOSPHO1, LNPK, SGMS2 PPARA 1774/4885PPARG 1254/4885CTSK 4331/4885
US-20130041180-A1 PROCESS FOR PREPARING (R)-2-ACETAMIDO-N-BENZYL-3-METHOXY-PROPIONAMIDE AMY1A, PTMA, NAAA PPARA 3037/4885PPARG 4153/4885CTSK 3441/4885
US-20250230165-A1 HETEROCYCLIC COMPOUNDS FOR USE IN THE TREATMENT OF CANCER NQO1, VHL, SDHA PPARA 634/4885PPARG 332/4885CTSK 1668/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.